Bruno Gagnon

Bruno Gagnon

Auto-generated profile, based on publicly available information

Bruno Gagnon

Department of Family Medicine and Emergency Medicine, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2020 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
CWCindy Wang
Cindy Wang
PGPamela Grassau
Pamela Grassau
PLPeter Gerard Lawlor
Peter Gerard Lawlor
CWColleen Webber
Colleen Webber
SBShirley H. Bush
Shirley H. Bush
ESEdward G. Spilg
Edward G. Spilg
Background: Physicians experience high rates of burnout, which may negatively impact patient care. Palliative care is an emotionally demanding specialty with high burnout rates reported in previous studies from other countries. We aimed to estimate the prevalence of burnout and degree of resilience among Canadian palliative care physicians and examine their associations with demographic and workplace factors in a national survey. Methods: Physician members of the Canadian Society of Palliative Care Physicians and Société Québécoise des Médecins de Soins Palliatifs were invited to participate in an electronic survey about their demographic and practice arrangements and complete the Maslach Burnout Inventory for Medical Professionals (MBI-HSS (MP)), and Connor-Davidson Resilience Scale (CD-RISC). The association of categorical demographic and practice variables was examined in relation to burnout status, as defined by MBI-HSS (MP) score. In addition to bivariable analyses, a multivariable logistic regression analysis, reporting odds ratios (OR), was conducted. Mean CD-RISC score differences were examined in multivariable linear regression analysis. Results: One hundred sixty five members (29%) completed the survey. On the MBI-HSS (MP), 36.4% of respondents reported high emotional exhaustion (EE), 15.1% reported high depersonalization (DP), and 7.9% reported low personal accomplishment (PA). Overall, 38.2% of respondents reported a high degree of burnout, based on having high EE or high DP. Median CD-RISC resilience score was 74, which falls in the 25th percentile of normative population. Age over 60 (OR = 0.05; CI, 0.01–0.38), compared to age ≤ 40, was independently associated with lower burnout. Mean CD-RISC resilience scores were lower in association with the presence of high burnout than when burnout was low (67.5 ± 11.8 vs 77.4 ± 11.2, respectively, p < 0.0001). Increased mean CD-RISC score differences (higher resilience) of 7.77 (95% CI, 1.97–13.57), 5.54 (CI, 0.81–10.28), and 8.26 (CI, 1.96–14.57) occurred in association with age > 60 as compared to ≤40, a predominantly palliative care focussed practice, and > 60 h worked per week as compared to ≤40 h worked, respectively. Conclusions: One in three Canadian palliative care physicians demonstrate a high degree of burnout. Burnout prevention may benefit from increasing resilience skills on an individual level while also implementing systematic workplace interventions across organizational levels.

1 July 2015 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
BGBruno Gagnon
Bruno Gagnon
LNLyne Nadeau
Lyne Nadeau
SSSusan Scott
Susan Scott
SDSerge Dumont
Serge Dumont
NMNeil MacDonald
Neil MacDonald
NMNancy Mayo
Nancy Mayo

28 June 2019 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
NMNadia Miladi
Nadia Miladi
RDRichi Dossa
Richi Dossa
MDMaman Joyce Dogba
Maman Joyce Dogba
MCMarie Immacula Fabienne Cléophat-Jolicoeur
Marie Immacula Fabienne Cléophat-Jolicoeur
BGBruno Gagnon
Bruno Gagnon

13 March 2024 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
BGBruno Gagnon
Bruno Gagnon
JMJessica Murphy
Jessica Murphy
DSDavid Simonyan
David Simonyan
CPClaudia A. Penafuerte
Claudia A. Penafuerte
JSJacinthe Sirois
Jacinthe Sirois
MTMichel L. Tremblay
Michel L. Tremblay
Background: The interdependence of cytokines and appetite‐modifying hormones implicated in cancer anorexia‐cachexia syndrome (CACS) remains unclear. This study aimed to regroup these cytokines and hormones into distinct inflammatory (or non‐inflammatory) pathways and determine whether these pathways can classify patients with CACS phenotypes.Methods: Clinical characteristics of 133 patients [61.7% male; mean age = 63.4 (SD: 13.1) years] with advanced cancer prior to oncology treatments were documented, including weight loss history. Patients completed the Functional Assessment of Anorexia‐Cachexia Therapy (FAACT) questionnaire and Timed Up and Go test and had their sex‐standardized skeletal muscle index (z‐SMI) and fat mass index (z‐FMI) derived using computed tomography scans. Their plasma levels of cytokines and appetite‐modifying hormones were also determined. Date of death was recorded. Exploratory factor analysis (EFA) was used to regroup 15 cytokines and hormone into distinct inflammatory pathways (factors). For each patient, regression factor scores (RFS), which tell how strongly the patient associates with each factor, were derived. Two‐step cluster analysis on the RFS was used to classify patients into groups. CACS phenotypes were correlated with RFS and compared between groups. Groups' survival was estimated using Kaplan–Meier analysis.Results: Patients had low z‐SMI (mean = −3.78 cm2/m2; SD: 8.88) and z‐FMI (mean = 0.08 kg2/m2; SD: 56.25), and 62 (46.6%) had cachexia. EFA identified three factors: (F‐1) IFN‐γ, IL‐1β, Il‐4, IL‐6, IL‐10, IL‐12, TGFβ1 (positive contribution), and IL‐18 (negative); (F‐2) IL‐8, IL‐18, MCP‐1, TGFβ1, TNF‐α (positive), and ghrelin (negative); and (F‐3) TRAIL and leptin (positive), and TGFβ1 and adiponectin (negative). RFS‐1 was associated with cachexia (P = 0.002); RFS‐2, with higher CRP (P < 0.0001) and decreased physical function (P = 0.01); and RFS‐3 with better appetite (P = 0.04), lower CRP (P = 0.002), higher z‐SMI (P = 0.04) and z‐FMI (P < 0.0001), and less cachexia characteristics (all P < 0.001). Four patient groups were identified with specific RFS clusters aligning with the CACS continuum from no cachexia to pre‐cachexia, cachexia, and terminal cachexia. Compared to the other two groups, groups 1 and 2 had higher plasma levels of IL‐18 and TRAIL. Group 1 also had lower inflammatory cytokines, adiponectin, and CRP compared to the other three groups. Group 3 had inflammatory cytokine levels similar to group 2, except for TNF‐α and leptin which were lower. Group 4 had very high inflammatory cytokines, adiponectin, and CRP compared to the other 3 groups (all P < 0.0001). Groups 3 and 4 had worse cachexia characteristics (P < 0.05) and shorter survival (log rank: P = 0.0009) than the other two groups.Conclusions: This exploratory study identified three distinct pathways of inflammation, or lack thereof, characterizing different CACS phenotypes.

21 March 2018 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
AAAla’ S Aburub
Ala’ S Aburub
BGB. Gagnon
B. Gagnon
SAS. Ahmed
S. Ahmed
ARA. M. Rodríguez
A. M. Rodríguez
NMNancy Mayo
Nancy Mayo

18 April 2024 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
AGAlexandra Guité-Verret
Alexandra Guité-Verret
JBJessica Boivin
Jessica Boivin
AHAndrew M. R. Hanna
Andrew M. R. Hanna
JDJames Downar
James Downar
SBShirley H. Bush
Shirley H. Bush
BGBruno Gagnon
Bruno Gagnon
Background: The practice of continuous palliative sedation until death is the subject of much medical and ethical debate, which is reflected in the inconsistency that persists in the literature regarding the definition and indications of palliative sedation. Aim: This study aims to gain a better understanding of palliative care clinicians’ experiences with continuous palliative sedation. Design: We conducted a qualitative study based on focus group discussions. Setting/participants: We conducted six focus groups with a total of 28 palliative care clinicians (i.e., 15 nurses, 12 physicians, and 1 end-of-life doula) from diverse care settings across Canada, where assisted dying has recently been legalized. Results: An interpretative phenomenological analysis was used to consolidate the data into six key themes: responding to suffering; grappling with uncertainty; adapting care to ensure ongoing quality; grounding clinical practice in ethics; combining medical expertise, relational tact, and reflexivity; and offering an alternative to assisted death. Conclusions: Interaction with the patient’s family, uncertainty about the patient’s prognosis, the concurrent practice of assisted dying, and the treatment of existential suffering influence the quality of sedation and indicate a lack of clear palliative care guidelines. Nevertheless, clinicians exhibit a reflective and adaptive capacity that can facilitate good practice.